Cargando…
Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study
OBJECTIVE: To compare the efficacy and safety of incobotulinumtoxinA with conventional antispastic therapy for poststroke arm spasticity in routine clinical practice over a 1-year period. DESIGN: Prospective, non-interventional, open-label, parallel-group study. SETTING: 47 centres in Germany. PARTI...
Autores principales: | Dressler, Dirk, Rychlik, Reinhard, Kreimendahl, Fabian, Schnur, Nicole, Lambert-Baumann, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710831/ https://www.ncbi.nlm.nih.gov/pubmed/26719317 http://dx.doi.org/10.1136/bmjopen-2015-009358 |
Ejemplares similares
-
Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
por: Santamato, Andrea
Publicado: (2016) -
Quality of life and costs of spasticity treatment in German stroke patients
por: Rychlik, Reinhard, et al.
Publicado: (2016) -
Erratum to: ‘Quality of life and costs of spasticity treatment in German stroke patients’
por: Rychlik, Reinhard, et al.
Publicado: (2016) -
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020) -
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017)